Hantz Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$118K Sell
3,238
-215
-6% -$7.84K ﹤0.01% 724
2025
Q1
$125K Buy
3,453
+86
+3% +$3.11K ﹤0.01% 601
2024
Q4
$142K Sell
3,367
-132
-4% -$5.57K ﹤0.01% 582
2024
Q3
$194K Buy
+3,499
New +$194K ﹤0.01% 567